IFNA1 and cancer: Moreover, CHIR 99021 is a GSK3 kinase inhibitor that can significantly enhance TNF and IFN production, natural cytotoxicity, and antibody-dependent cellular cytotoxicity for effective cancer immunotherapy (60).